Bolt Biotherapeutics Statistics

Total Valuation

BOLT has a market cap or net worth of $25.63 million. The enterprise value is -$29.17 million.

Market Cap	25.63M
Enterprise Value	-29.17M

Important Dates

The next estimated earnings date is Thursday, November 7, 2024, after market close.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

BOLT has 38.26 million shares outstanding. The number of shares has increased by 1.04% in one year.

Shares Outstanding	38.26M
Shares Change (YoY)	+1.04%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	3.98%
Owned by Institutions (%)	28.24%
Float	25.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.28
Forward PS	n/a
PB Ratio	0.30
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.28, with a Debt / Equity ratio of 0.22.

Current Ratio	4.28
Quick Ratio	4.13
Debt / Equity	0.22
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -58.04% and return on invested capital (ROIC) is -34.50%.

Return on Equity (ROE)	-58.04%
Return on Assets (ROA)	-29.41%
Return on Capital (ROIC)	-34.50%
Revenue Per Employee	$111,660
Profits Per Employee	-$661,660
Employee Count	100
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.49% in the last 52 weeks. The beta is 0.93, so BOLT's price volatility has been similar to the market average.

Beta (5Y)	0.93
52-Week Price Change	-29.49%
50-Day Moving Average	0.65
200-Day Moving Average	0.90
Relative Strength Index (RSI)	57.66
Average Volume (20 Days)	127,818

Short Selling Information

The latest short interest is 119,446, so 0.31% of the outstanding shares have been sold short.

Short Interest	119,446
Short Previous Month	119,132
Short % of Shares Out	0.31%
Short % of Float	0.48%
Short Ratio (days to cover)	0.86

Income Statement

In the last 12 months, BOLT had revenue of $11.17 million and -$66.17 million in losses. Loss per share was -$1.74.

Revenue	11.17M
Gross Profit	-52.07M
Operating Income	-74.07M
Pretax Income	-63.03M
Net Income	-66.17M
EBITDA	-72.23M
EBIT	-74.07M
Loss Per Share	-$1.74

Full Income Statement

Balance Sheet

The company has $73.70 million in cash and $18.89 million in debt, giving a net cash position of $54.81 million or $1.43 per share.

Cash & Cash Equivalents	73.70M
Total Debt	18.89M
Net Cash	54.81M
Net Cash Per Share	$1.43
Equity (Book Value)	85.86M
Book Value Per Share	2.24
Working Capital	58.73M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$63.91 million and capital expenditures -$171,000, giving a free cash flow of -$64.08 million.

Operating Cash Flow	-63.91M
Capital Expenditures	-171,000
Free Cash Flow	-64.08M
FCF Per Share	-$1.67

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-663.38%
Pretax Margin	-592.57%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-557.05%

Dividends & Yields

BOLT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.04%
Shareholder Yield	-1.04%
Earnings Yield	-258.12%
FCF Yield	-249.98%

Analyst Forecast

The average price target for BOLT is $1.25, which is 86.60% higher than the current price. The consensus rating is "Hold".

Price Target	$1.25
Price Target Difference	86.60%
Analyst Consensus	Hold
Analyst Count	5
Revenue Growth Forecast (5Y)	26.49%
EPS Growth Forecast (5Y)	-26.30%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BOLT has an Altman Z-Score of -5.13 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.13
Piotroski F-Score	3